IL297780A - Controlled modification of adeno-associated virus (aav) for enhanced gene therapy - Google Patents
Controlled modification of adeno-associated virus (aav) for enhanced gene therapyInfo
- Publication number
- IL297780A IL297780A IL297780A IL29778022A IL297780A IL 297780 A IL297780 A IL 297780A IL 297780 A IL297780 A IL 297780A IL 29778022 A IL29778022 A IL 29778022A IL 297780 A IL297780 A IL 297780A
- Authority
- IL
- Israel
- Prior art keywords
- aav
- amino acid
- genetically
- modified
- variant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14145—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018573P | 2020-05-01 | 2020-05-01 | |
| PCT/US2021/030489 WO2021222899A1 (en) | 2020-05-01 | 2021-05-03 | Controlled modification of adeno-associated virus (aav) for enhanced gene therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL297780A true IL297780A (en) | 2022-12-01 |
Family
ID=76392408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL297780A IL297780A (en) | 2020-05-01 | 2021-05-03 | Controlled modification of adeno-associated virus (aav) for enhanced gene therapy |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230175013A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4143206A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7862320B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230005941A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115551878A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021264081A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3177573A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL297780A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222899A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116333058A (zh) * | 2023-02-14 | 2023-06-27 | 国家纳米科学中心 | 可定点修饰抗原的病毒样颗粒及其构建方法与应用 |
| WO2025188967A1 (en) | 2024-03-06 | 2025-09-12 | Trustees Of Boston College | Precise adeno-associated virus-protein conjugates and uses thereof |
| TW202609054A (zh) * | 2024-05-01 | 2026-03-01 | 日商Jcr製藥股份有限公司 | 經修飾之aav粒子、其製造方法、相關之醫藥及其製造方法 |
| WO2026037731A1 (en) | 2024-08-12 | 2026-02-19 | Coave Therapeutics | Squaramide-modified viral vectors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4480268B2 (ja) * | 1998-02-12 | 2010-06-16 | イミューン コンプレックス コーポレイション | 戦略的修飾されたb型肝炎コアタンパク質及びそれらの誘導体 |
| PL2657248T3 (pl) * | 2003-06-19 | 2017-09-29 | Genzyme Corporation | Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie |
| EP1828390B1 (en) * | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| EP2396343B1 (en) * | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| CN104592364B (zh) * | 2013-10-30 | 2018-05-01 | 北京大学 | 定点突变和定点修饰的腺相关病毒、其制备方法及应用 |
| JP6836999B2 (ja) * | 2015-03-24 | 2021-03-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | アデノ随伴ウイルス変異体及びその使用方法 |
| WO2019221992A1 (en) * | 2018-05-15 | 2019-11-21 | President And Fellows Of Harvard College | Viral vectors exhibiting improved gene delivery properties |
-
2021
- 2021-05-03 KR KR1020227042010A patent/KR20230005941A/ko active Pending
- 2021-05-03 EP EP21731860.9A patent/EP4143206A1/en active Pending
- 2021-05-03 US US17/922,425 patent/US20230175013A1/en active Pending
- 2021-05-03 WO PCT/US2021/030489 patent/WO2021222899A1/en not_active Ceased
- 2021-05-03 CA CA3177573A patent/CA3177573A1/en active Pending
- 2021-05-03 CN CN202180032267.7A patent/CN115551878A/zh active Pending
- 2021-05-03 JP JP2022563990A patent/JP7862320B2/ja active Active
- 2021-05-03 AU AU2021264081A patent/AU2021264081A1/en active Pending
- 2021-05-03 IL IL297780A patent/IL297780A/en unknown
-
2025
- 2025-12-19 JP JP2025267976A patent/JP2026062759A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021222899A1 (en) | 2021-11-04 |
| JP2026062759A (ja) | 2026-04-10 |
| EP4143206A1 (en) | 2023-03-08 |
| JP2023524401A (ja) | 2023-06-12 |
| US20230175013A1 (en) | 2023-06-08 |
| CN115551878A (zh) | 2022-12-30 |
| CA3177573A1 (en) | 2021-11-04 |
| KR20230005941A (ko) | 2023-01-10 |
| AU2021264081A1 (en) | 2022-11-03 |
| JP7862320B2 (ja) | 2026-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE062774T2 (hu) | Módosított rAAV kapszidfehérje génterápiához | |
| EP3856913A4 (en) | Adeno-associated virus compositions for targeted gene therapy | |
| PL3999119T3 (pl) | Modyfikowane białka kapsydu aav do leczenia choroby zapalnej stawów | |
| EP3575398A4 (en) | ADENO-ASSOCIATED VIRUS (AAV) CAPSIDE PROTEIN MUTANT | |
| IL280636A (en) | Alternative splicing regulation of gene expression and therapeutic methods | |
| IL280637A (en) | Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia b | |
| IL285238A (en) | Gene therapy vectors for treatment of danon disease | |
| CL2022000939A1 (es) | Vectores virales adenoasociados para el tratamiento de la enfermedad de niemann-pick tipo c | |
| IL299380A (en) | An improved adenovirus as a vector for gene therapy | |
| AU2019265855B2 (en) | Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies | |
| EP4013770A4 (en) | AAV CAPSID VARIANTS FOR GENE THERAPY | |
| EP3953484A4 (en) | Aav-mediated gene therapy for maple syrup urine disease (msud) | |
| IL287614A (en) | Adeno-associated virus (aav) particles modified for gene therapy | |
| EP4179098A4 (en) | GENE THERAPY FOR STXBP1 ENCEPHALOPATHY | |
| EP4048794A4 (en) | Triple function adeno-associated virus (aav) vectors for the treatment of c9orf72 associated diseases | |
| IL307604A (en) | Adenoviral gene therapy vectors | |
| EP3844294A4 (en) | GENE THERAPY FOR THE TREATMENT OF GALACTOSEMIA | |
| EP3802576A4 (en) | FLOWMETER WITH FITTING WITH DRAIN TANK, TAP AND PLUG | |
| DK3864053T3 (da) | Behandling af rms ved at skifte terapi | |
| IL285329A (en) | Adeno-associated virus delivery of cln6 polynucleotide | |
| EP4359519A4 (en) | Adeno-associated viral (AAV) vectors for targeted tissue expression of therapeutic genes | |
| EP4267200A4 (en) | ADENOVIRAL VECTORS FOR GENE THERAPY | |
| EP4743105A1 (en) | VAA-BASED GENE THERAPY APPROACH FOR THE TREATMENT OF LGMD2B/DYSFERLINOPATHY | |
| EP4106799A4 (en) | ADENO-ASSOCIATED VIRAL (AAV)-MEDIATED SGPL1 GENE THERAPY FOR THE TREATMENT OF SPHINGOSINE-1-PHOSPHATE LYASE DEFICIENCY SYNDROME (SPLIS) | |
| IL310017A (en) | Retgc gene therapy |